Close menu




Gold price

Photo credits: pixabay.com

Commented by Lars Winter on October 20th, 2026 | 05:44 CEST

Gold, Money and Healthcare: Lahontan Gold, Goldman Sachs and Johnson & Johnson – 3 Promising Stocks Under Review

  • Gold
  • Gold mine
  • Gold price
  • Commodities
  • Precious metal
  • Mining
  • Banks
  • Financial services providers
  • Pharmaceutical industry
  • Medicines
  • Health
  • Medicine

Canadian gold exploration company Lahontan Gold is generating optimism. A preliminary economic assessment of its key mining project in Nevada recently assigned the Santa Fe Mine a calculated project value of USD 820 million. This is a multiple of its current market capitalisation, giving the stock considerable upside potential. Goldman Sachs has also surprised the market in recent days with a strong set of financial results. Pharmaceutical giant Johnson & Johnson, meanwhile, raised its outlook despite one minor setback. Three promising companies with positive news are under review.

Read

Commented by Armin Schulz on October 14th, 2026 | 05:41 CEST

Barrick Mining, Lahontan Gold and Agnico Eagle: Gold Stocks Spanning Production, Mine Restart and Strategic Investments

  • Barrick Mining
  • Lahontan Gold
  • Agnico Eagle
  • Gold
  • Copper
  • Spin-Off
  • Nevada
  • Gold production
  • Gold producer
  • Gold price
  • Holdings

Since 2019, Barrick Mining has invested about USD 5.3 billion in Tanzania's economy, according to its own figures, and it extended the licences for the North Mara gold mine by 15 years in early October. This provides planning certainty. Smaller companies also have big plans. Lahontan Gold agreed to acquire Emergent Metals in mid-September and is targeting a 2027 restart of the Santa Fe mine in Nevada. If it succeeds, the high gold price works in the company's favour. Agnico Eagle shows that major producers are also interested in emerging companies. We therefore take a closer look at Barrick Mining, Lahontan Gold and Agnico Eagle.

Read